|
18 Jan 2017
Merck has introduced CAN MultiFlow™ screening services to more accurately predict genotoxic and mode of action* properties of substances, ingredients and drug compounds
|
20170118 |
|
|
17 Jan 2017
Merck today announced the opening of a facility in Mollet des Vallès, Spain dedicated to the manufacture of meglumine, an FDA-approved excipient for pharmaceuticals and a component of medical imaging contrast media.
|
20170117 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
05 Dec 2016
Merck today announced that it will provide its Provantage® End-to-End services to Acticor Biotech SAS for accelerated development and manufacturing of Acticor’s antibody fragment used for the primary treatment of ischemic stroke.
|
20161205 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
02 Dec 2016
Merck today introduced Parteck® MXP, a polyvinyl alcohol-based excipient that enhances solubility of a wide range of active pharmaceutical ingredients (APIs) with poor bioavailability.
|
20161202 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
06 Oct 2016
Merck today announced the opening of an M Lab™ Collaboration Center in the Songdo district of Incheon, Korea, one of the fastest growing biotech hubs in Asia.
|
20161006 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
05 Oct 2016
Merck today announced that the CEO of its life science business, Udit Batra, was named “CEO of the Year” for 2016 by CPhI Pharma for his commitment to furthering life science innovation globally.
|
20161005 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
26 Sep 2016
Merck is launching the Viresolve® Pro Shield H for removal of parvoviruses from therapeutic protein feed streams.
|
20160926 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
08 Sep 2016
Merck today launched a first-of-its-kind gene editing technology to modify CHO cell lines to be resistant to minute virus of mice (MVM), a common contamination threat that remains despite the shift to chemically defined, animal component-free manufacturing processes.
|
20160908 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
01 Aug 2016
Merck will provide its Provantage® End-to-End development and manufacturing services to Y-mAbs Therapeutics, Inc. in support of Y-mAbs’ monoclonal antibody in late stage clinical development.
|
20160801 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
18 Jul 2016
Merck is relaunching its global network of customer collaboration centers, providing customers a shared, exploratory environment with scientists and engineers working to solve their toughest biomanufacturing challenges and helping accelerate development of new therapies.
|
20160718 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
12 Jul 2016
Merck has entered into an agreement with PCAS S.A. (Longjumeau, France) to expand Merck’s excipients portfolio.
|
20160712 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
28 Jun 2016
Merck has expanded its industry-leading Emprove® risk assessment program to include a selection of products for filtration and single-use processing.
|
20160628 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
28 Jun 2016
Merck has entered a research agreement with the International Vaccine Institute (IVI) of Seoul, South Korea to help develop more robust, scalable vaccine manufacturing processes.
|
20160628 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
07 Jun 2016
Merck today announced survey results of 250 global biopharmaceutical executives on how their companies will manage new risks associated with the changing biopharma landscape.
|
20160607 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
02 May 2016
Merck today announced the expansion of its state-of-the art single use current good manufacturing process (cGMP) facility with the addition of the Mobius® 2000L single-use bioreactor.
|
20160502 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
04 May 2016
Merck today announced an expansion of its Carlsbad, California facility to meet growing demand for viral and gene therapy products.
|
20160504 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
27 Apr 2016
Merck is launching three Mobius® products that deliver improved efficiency and ease-of-use for biopharmaceutical manufacturing workflows.
|
20160427 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
26 Apr 2016
Merck today announced the launch of its first-in-class Lynx® CDR connectors to improve fluid management in the biopharma industry.
|
20160426 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
26 Oct 2015
Merck today introduced Parteck® SRP 80, a new functional excipient for oral sustained-release formulations.
|
20151026 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
22 Oct 2015
Merck today announced the Company has entered into a strategic alliance with Turgut Ilaç, a leading biosimilars company based in Turkey and will provide their Provantage® End-to-End services for development and manufacturing of biologics.
|
20151022 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
21 Oct 2015
Merck today introduced Millipore Express® PHF (process protection, high-flux) hydrophilic filters for fast, efficient and economical buffer filtration.
|
20151021 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
28 Sep 2015
Merck today announced that it has published an original white paper, recognizing the impact the emerging biotech community has on the future of healthcare.
|
20150928 |
Water Purification,Small Molecule Pharmaceuticals,Reagents Chemicals and Labware,Life Science Research,Industrial Biomonitoring,IVD/OEM Materials and Reagents,Biopharmaceutical Manufacturing,Analytics and Sample Preparation |
|
14 Sep 2015
Merck today introduced enhancements to its industry-leading Emprove® portfolio of pharmaceutical raw materials.
|
20150914 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
27 Jul 2015
Merck today announced a collaboration with celares GmbH to provide pegylation services to customers developing protein-based therapeutics and biosimilars.
|
20150727 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
15 Jun 2015
Merck today introduced the Mobius® 2000 liter single-use bioreactor. The 2000 liter bioreactor joins the Mobius® stirred tank bioreactor portfolio (from 3 to 2000 liters) that provides the ultimate in flexibility, scalability, and convenience.
|
20150615 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
15 Jun 2015
Merck today announced expansion of its Provantage® Biodevelopment Services to include a Clone Generation Service.
|
20150615 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
02 Jun 2015
Merck today introduced a new technology that compacts dry powder cell culture media into granules, accelerating solubility and improving flowability and handling.
|
20150602 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
01 Jun 2015
Merck today announced the launch of its Cellvento™ CHO platform of cell culture media and companion feed formulations for batch, fed-batch and perfusion applications.
|
20150601 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
21 May 2015
Merck today introduced single-pass tangential flow filtration (TFF) with Pellicon® cassettes, an enhanced application of Merck’s existing TFF technology that allows concentration of process streams without the recirculation required in traditional TFF.
|
20150521 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
02 Feb 2015
Merck today announced an agreement for providing upstream process development services for Precision Biologics, Inc., a Texas-based clinical-stage biotechnology company, to advance a preclinical monoclonal antibody.
|
20150202 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
21 Oct 2014
Merck has expanded its single-use film offerings with the introduction of PureFlex™ Plus film, a robust, durable film used in the construction of Mobius® single-use process containers for biopharmaceutical manufacturing.
|
20141021 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
15 Sep 2014
Merck announced it has received two R&D Magazine 100 Awards for innovative products released to market in 2013.
|
20140915 |
Small Molecule Pharmaceuticals,Life Science Research,Biopharmaceutical Manufacturing |
|
20 Aug 2014
Merck announced today that Merck and Samsung BioLogics signed an MOU (Memorandum of Understanding) for a strategic alliance on the biopharmaceutical business.
|
20140820 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
05 May 2014
Merck Millipore today announces the expansion of its upstream services into North America as part of its Provantage® Biodevelopment and Clinical Supply offering.
|
20140505 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
04 Feb 2014
The DRYPOUR™ packaging system minimizes caking of hygroscopic salts used in pharmaceutical manufacturing during transport and storage.
|
20140204 |
Biopharmaceutical Manufacturing,Small Molecule Pharmaceuticals |
|
29 Jan 2014
The portfolio includes EMPROVE® api for active pharmaceutical ingredients, EMPROVE® exp for excipients and EMPROVE® bio for biopharmaceutical materials.
|
20140129 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
04 Jun 2012
This new application facilitates large-scale production at up to one-third the cost per dose compared to cells grown in flat culture stacks.
|
20120604 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
07 Aug 2012
CellPrime™ Insulin stimulates the proliferation of cells and aids in carbohydrate metabolism, helping to ensure the long-term viability of various cell lines.
|
20120807 |
Biopharmaceutical Manufacturing |
|
02 May 2013
Merck Millipore announced the settlement of patent infringement disputes between Merck Millipore and W.L. Gore & Associates, Inc. in the U.S. District Court for the District of Massachusetts.
|
20130502 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
15 Nov 2012
Built on Merck Millipore’s proven Eshmuno resin technology, the new media offers high aggregate removal efficiency and high dynamic binding capacity, supporting highly productive downstream bioprocessing.
|
20121115 |
Biopharmaceutical Manufacturing |
|
25 Jun 2012
Donovan joined Millipore Corporation in 1988 and has held numerous sales leadership roles including Senior Director, North American Field Operations, and Director of Sales.
|
20120625 |
Biopharmaceutical Manufacturing |
|
17 Sep 2013
Novel Clarisolve Depth Filters Deliver Unmatched Speed and Efficiency for Single-Stage Clarification of Pretreated Feed Streams
|
20130917 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
27 Feb 2012
Merck Millipore and Charles River will collaborate to integrate the TrueSpike™ technology into viral clearance services provided by Charles River.
|
20120227 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
12 Mar 2012
This joint project will focus on the development of a proprietary monitoring and control methodology, enabling robust growth of adherent human pluripotent stem cells.
|
20120312 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
05 Sep 2012
The new media formulation was designed for the long-term growth of Chinese Hamster Ovary (CHO) cells to express antibodies or protein products.
|
20120905 |
Biopharmaceutical Manufacturing |
|
24 Jun 2013
Cellvento™ CHO-200 medium and its corresponding feeds do not contain hydrolysates or components of unknown composition, resulting in very good lot-to-lot consistency.
|
20130624 |
Biopharmaceutical Manufacturing |
|
01 Mar 2012
The increased efficiency offered by CellPrime recombinant human lysozyme, combined with high activity levels, results in a reduction of overall production costs.
|
20120301 |
Biopharmaceutical Manufacturing |
|
01 May 2013
He will assume leadership effective May 14, 2012 and be based at the company’s U.S. headquarters in Massachusetts.
|
20130501 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
19 Sep 2012
This project will focus on the development required to ensure removal of microcarriers and any particulates from stem cell products grown in the Mobius® CellReady disposable bioreactor.
|
20120919 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
09 Oct 2012
This includes products for all types of dosage forms that address solubility, PK/PD modification, which must be taken into account for optimized bioavailability in the final drug.
|
20121009 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
01 Nov 2012
The two companies are jointly developing a methodology utilizing Sistemic’s microRNA marker detection capability to enable consistent growth of stem cells.
|
20121101 |
Small Molecule Pharmaceuticals,Life Science Research,Biopharmaceutical Manufacturing |
|
14 Aug 2012
PureGenome library preparation is a simple, two-step process followed by amplification using Merck Millipore’s ultra-high fidelity KOD Hot Start DNA Polymerase Mastermix.
|
20120814 |
Reagents Chemicals and Labware,Life Science Research |
|
20 Jun 2012
Provantage Solutions provide greater control and increased flexibility for both small and large molecule development and manufacturing processes.
|
20120620 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
21 May 2013
The companies will work together to produce protocols and methods for efficient expansion, harvest and use of HepaRG® cells in support of the BALANCE project.
|
20130521 |
Biopharmaceutical Manufacturing |
|
10 Apr 2012
Presentations and discussions will explore the recent launch of the new excipients certification program EXCiPACT™.
|
20120410 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
22 Oct 2013
Featuring a unique pore structure, Parteck SLC for drug delivery enables loading of oral dosage forms with amorphously distributed API to the highest levels.
|
20131022 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
08 Aug 2012
This novel design protects product integrity and prevents product loss during sample collection, transport and especially during long term storage where stress release can induce leakage.
|
20120808 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
12 Jul 2013
The center will accelerate growth of the company’s portfolio of innovative technologies and products that overcome bioavailability and formulation challenges
|
20130712 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
20 Sep 2012
The site will serve users of Merck Millipore’s Provantage™ Biodevelopment and Clinical Supply Solutions option that incorporates the latest technologies for upstream and downstream processes.
|
20120920 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
07 Jan 2013
Unlike traditional single-use processing systems, this modular system is quick and easy to set up, providing the ability to switch from TFF to Chromatography.
|
20130107 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
06 Aug 2012
The Mobius FlexReady Solution with Smart Flexware Assemblies for Chromatography is a fully-automated system designed to achieve optimum performance.
|
20120806 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
15 Mar 2012
This new single-use bioreactor allows biopharmaceutical manufacturers to implement robust, single-use technologies that bring their drugs to market faster, with less risk.
|
20120315 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
12 Feb 2012
With the Millistak+ µPod filter, users can easily connect multiple devices in parallel or series to rapidly screen combinations of media.
|
20120212 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
22 Oct 2013
The electronic Original Manufacturer Tracking (eOMT) saves users valuable time in research and enables compliance with regulatory requirements.
|
20131022 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
18 Sep 2012
Large-scale production of stem cells is necessary to enable their advancement into human clinical trials and to effectively deliver the quantities required.
|
20120918 |
Small Molecule Pharmaceuticals,Life Science Research,Biopharmaceutical Manufacturing |
|
21 Mar 2012
This product, which utilizes Ventria’s ExpressTec biomanufacturing technology, will be exclusively marketed and distributed by Merck Millipore to its customers on a global basis.
|
20120321 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
13 Nov 2012
User Group Meetings attract global biotechnology and biopharmaceutical industry professionals, including those in chromatography R&D, process development, production management and engineering.
|
20121113 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
18 Oct 2012
The price adjustments are being driven by recent and anticipated cost increases, macroeconomic trends and inflation among other considerations.
|
20121018 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
